2022-04-04

NJBIZ Conversations: Chris Beddard

Chris Beddard, Vice President, U.S. Marketing, Integrated Diagnostic Solutions at BD

Chris Beddard is the Vice President, U.S. Marketing, Integrated Diagnostic Solutions at BD.

In this interview with NJBIZ, she speaks about the BD Onclarity™ HPV Assay, an HPV test with extended genotyping that holds the promise of improved outcomes. As long as women use it.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

Child with woman smiling
Cervical Cancer | Brochures
Identify HPV 31 with BD Onclarity™ HPV Assay
Modern Healthcare: How is extended genotyping shaping the future of cervical cancer screening?
Cervical Cancer | News & Updates
Modern Healthcare: How is extended genotyping shaping the future of cervical cancer screening?
ReachMD: Genotype specific persistence: Looking beyond HPV 16
Cervical Cancer | Webinars & Videos
ReachMD: Genotype specific persistence: Looking beyond HPV 16